Namwiwat Medical PCL (BKK:NAM) Ending Cash Position: ฿677 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:NAM Namwiwat Medical Corp PCL BKK:NAM
35 GF Score
Price ฿3.30
GF Value ฿5.88
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Namwiwat Medical PCL Ending Cash Position?

Namwiwat Medical PCL BKK:NAM 35 Ending Cash Position is ฿677 Mil as of Mar. 2026. GuruFocus rates BKK:NAM with a GF Score™ of 35/100 and a GF Value™ of ฿5.88 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Namwiwat Medical PCL's Ending Cash Position for the quarter that ended in Mar. 2026 was ฿677 Mil.

Namwiwat Medical PCL's quarterly Ending Cash Position increased from Sep. 2025 (฿696 Mil) to Dec. 2025 (฿698 Mil) but then declined from Dec. 2025 (฿698 Mil) to Mar. 2026 (฿677 Mil).

Namwiwat Medical PCL's annual Ending Cash Position declined from Dec. 2023 (฿996 Mil) to Dec. 2024 (฿921 Mil) and declined from Dec. 2024 (฿921 Mil) to Dec. 2025 (฿698 Mil).

Namwiwat Medical PCL Ending Cash Position Related Terms

Namwiwat Medical PCL Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Namwiwat Medical PCL's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Namwiwat Medical PCL Ending Cash Position Chart

Namwiwat Medical PCL Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 40.64 59.02 995.66 920.84 697.82

Namwiwat Medical PCL Quarterly Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 886.66 634.14 695.63 697.82 677.03
BKK:NAM
35GF Score
Namwiwat Medical Corp PCL BKK:NAM
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Namwiwat Medical PCL Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Namwiwat Medical PCL's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=920.841+-223.017
=698

Namwiwat Medical PCL's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=697.825+-20.798
=677

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of ฿677 Mil mean?
Namwiwat Medical PCL (BKK:NAM) has a Ending Cash Position of ฿677 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Namwiwat Medical PCL and its competitors.
Is Namwiwat Medical PCL's Ending Cash Position too high?
Namwiwat Medical PCL's current Ending Cash Position is ฿677 Mil. Overall, Namwiwat Medical PCL has a GF Score™ of 35/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Namwiwat Medical PCL's Ending Cash Position compare to ABT and SYK?
Namwiwat Medical PCL's Ending Cash Position of ฿677 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Namwiwat Medical PCL and its competitors. Namwiwat Medical PCL's current Ending Cash Position is ฿677 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Namwiwat Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Namwiwat Medical PCL (BKK:NAM) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿5.88, compared to a current price of ฿3.30 — trading 43.9% below its estimated fair value. The current Ending Cash Position is ฿677 Mil. Namwiwat Medical PCL's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Namwiwat Medical PCL (BKK:NAM), the current Ending Cash Position is ฿677 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Namwiwat Medical PCL (BKK:NAM) Overvalued in 2026?

Based on GuruFocus' analysis, Namwiwat Medical PCL stock appears to be undervalued. The current stock price of ฿3.30 is trading 43.9% below its estimated GF Value™ of ฿5.88. GuruFocus considers Namwiwat Medical PCL to be Significantly Undervalued.

Key valuation signals for BKK:NAM:

  • Ending Cash Position: ฿677 Mil
  • GF Value™: ฿5.88 vs. price of ฿3.30 (43.9% below fair value)
  • GF Score™: 35/100 with 3 warning signs

No single metric tells the full story. See the BKK:NAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Namwiwat Medical PCL Business Description

Address 999/3-5 Moo 9 Prachauthit - Ku Sang Road, Nai Khlong Bang Pla Kot, Phra Samut Chedi, Samut Prakan, THA, 10290
Namwiwat Medical Corp PCL operates a manufacturing business, importing and distributing Medical tools and equipment for cleaning and disinfecting medical equipment in hospitals and nursing homes in accordance with public health standards. The Group has a total of three reporting segments as follows: Medical equipment manufacturing and distribution segment; Medical supplies manufacturing and distribution segment; CSSD disinfection Medical equipment maintenance services segment, and waste services segment. The Group operates its business in one geography, only in Thailand.
35GF Score

Get the complete analysis for BKK:NAM

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿3.30
Price
฿5.88
GF Value